Alcami Announces CEO Transition
Bill Humphries to succeed Patrick Walsh as CEO effective June 5th, 2023
- Bill Humphries to succeed Patrick Walsh as CEO effective June 5th, 2023
WILMINGTON, N.C., June 5, 2023 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the retirement of Patrick Walsh and the subsequent appointment of Bill Humphries as the next CEO, effective June 5th, 2023.
- Prior to Alcami, Humphries' executive leadership roles included CEO at Isosceles Pharmaceuticals, President and Group Company Chairman of Ortho-Dermatologics, CEO of Merz North America, President of Stiefel, a GSK Company and Vice President of US Skincare at Allergan Pharmaceuticals.
- He further commented, "I feel fortunate that Pat is remaining in the Alcami family, and the opportunity to work with the Alcami team, Pat, our outstanding Board members and Partners provides me every confidence in the future growth of Alcami."
- With this transition, we are delighted to welcome Bill Humphries as our new CEO.